Stay updated with breaking news from Nasdaq Bcab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JMP Securities restated their market outperform rating on shares of BioAtla (NASDAQ:BCAB – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $12.00 price target on the stock. Other research analysts have also recently issued research reports about the stock. EF Hutton Acquisition Co. I restated a buy rating […]
BioAtla, Inc. (NASDAQ:BCAB – Get Free Report) saw a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 4,620,000 shares, a growth of 25.9% from the June 15th total of 3,670,000 shares. Based on an average daily volume of 531,100 shares, the short-interest ratio is […]
Shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) have received a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price […]
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) has been given an average rating of “Moderate Buy” by the six ratings firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among brokers […]
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 3,590,000 shares, a decline of 5.0% from the April 30th total of 3,780,000 shares. Based on an average trading volume of 499,900 shares, the short-interest […]